Synplogen
Kobe
About Synplogen
Synplogen is a start-up company that brings together unique DNA synthesis technologies that Kobe University and others have been developing for nearly 10 years. Utilizing state-of-the-art genetic engineering, information science, and robotics, Synplogen have the technology to synthesize high-throughput.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $884.8K
- Last round: Series Unknown (Nov 2021)
- Website: synplogen.com
- Phone: [email protected]
Industries & Categories
Biometrics, Biopharma, Biotechnology
Canonical: https://fsome.com/organization/synplogen-132533 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.